US EditionLetko Brosseau & Associates Inc. Increases Stock Holdings in Pfizer Inc. (NYSE:PFE)
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Letko Brosseau & Associates Inc. Increases Stock Holdings in Pfizer Inc. (NYSE:PFE)
Letko Brosseau & Associates Inc. boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 29.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,863,988 shares of the biopharmaceutical company’s stock after buying an additional 872,530 shares during the quarter. Pfizer […]
Pfizer at a Crossroads: Navigating the Turbulent Waters of Decline
Pfizer, a once-unassailable titan in the pharmaceutical world, now finds itself at a critical crossroads. A company that soared to new heights with the advent of the COVID-19 vaccine and Paxlovid is now grappling with an unprecedented decline in stock value, reduced revenues, and strategic missteps. As of May 2025, the stock price has hit […] The post Pfizer at a Crossroads: Navigating the Turbulent Waters of Decline appeared first on CCE l ONLI…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
